about
Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoidsWhere is it and How Does it Get There - Intracellular Localization and Traffic of P-glycoproteinMolecular biology of cantharidin in cancer cellsThe phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporterFunctionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitroLocalized Down-regulation of P-glycoprotein by Focused Ultrasound and Microbubbles induced Blood-Brain Barrier Disruption in Rat Brain.Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line.High P-glycoprotein-mediated export observed in patients with a history of idiopathic thrombocytopenic purpura.Multidrug resistance reversal effect of DMC derived from buds of Cleistocalyx operculatus in human hepatocellular tumor xenograft model.N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin tSensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group.Role of receptor tyrosine kinases and their ligands in glioblastoma.Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.Drug resistance in brain diseases and the role of drug efflux transporters.TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases.Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cellsHerbal modulation of P-glycoprotein.Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell linesComparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity?Cancer chemoresistance: the relationship between p53 and multidrug transporters.Molecular and pharmacological strategies to overcome multidrug resistance.Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance.Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Molecular mechanisms of drug resistance in single-step and multi-step drug-selected cancer cells.Beta-Amyloid Downregulates MDR1-P-Glycoprotein (Abcb1) Expression at the Blood-Brain Barrier in Mice.2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance.Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.Translational molecular imaging for cancer.Structure and function of efflux pumps that confer resistance to drugsIdentification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.Cyclostreptin derivatives specifically target cellular tubulin and further map the paclitaxel site.P glycoprotein in human immunodeficiency virus type 1 infection and therapy.Multidrug resistance proteins in rheumatoid arthritis, role in disease-modifying antirheumatic drug efficacy and inflammatory processes: an overview.MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.Stereoselective Modulation of P-Glycoprotein by Chiral Small Molecules.Automated synthesis of 18F analogue of paclitaxel (PAC): [18F]Paclitaxel (FPAC).Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
P2860
Q24796455-7B9C60C6-48B4-493B-81C5-E21DB6235827Q27008624-F9939A5D-8080-42D9-AEF5-A596F7744314Q27480937-FB28641B-243C-423B-BF73-1524176671E7Q28477938-F2F1C566-1F26-4FCB-A580-B5541B8C09C2Q28488394-874F4E9E-5D21-41A5-9CE9-7245A97CEAF2Q30376238-AA3A1B04-6D79-4A61-A47A-22AD5D603686Q30385768-7ABFA731-623C-476B-B411-7671E7F08AD8Q33330221-380C7377-CD3F-4226-9C03-CED8C67C4D5BQ33343771-A1DB3257-7B48-490F-BCB8-42110079B195Q33351826-9784372D-2BA0-49CD-8879-37492A27CEAFQ33370268-0EFC9704-00A1-4F79-8373-1822BCB23EE4Q33559358-93CD6D90-30E5-49ED-81F8-DAD96AA185BAQ33729158-6AA5C6E0-A7B2-4101-9475-B0D43F855024Q33883849-F40242F3-AA57-4966-8C25-D4FAD7E91656Q33985133-96F1C13B-8263-4A7F-81BC-6A86CA9C5B5AQ33988704-BAB37BFB-08EC-496E-84DC-32A92FA91871Q34053698-68A7A01A-B1CA-4C79-ADED-B55364EA62F4Q34166391-9E888419-510C-4095-A239-2916BD188795Q34312035-C6347A63-8400-4468-A5EF-68079B1A0E2CQ34356546-85DA7F64-10CF-4B75-A89E-E59222133A68Q34478388-0641C6A4-84AC-4D17-BC75-7343195DFF81Q34580489-0182FE21-48A0-4CDB-B141-878A4CDDBC09Q34734178-1E9ED5E2-C0AF-4106-BF60-CD61B5250BD3Q34811676-5D9D7E12-EECD-4B01-B390-98755F454B02Q34994901-7F169471-4FA5-4421-8FE1-E2C66D70D664Q34996536-5323BB86-F08D-4A60-BE6F-68B7EE06AB85Q35030142-1AA6DD4E-8947-4B23-BF2D-3FA8DF6E4A3CQ35110635-770D5C48-9D73-4BC9-859D-A17EBBE538B3Q35130652-287970F4-73CA-4B82-A0CA-A30A78DFF938Q35173093-A27DB3BB-3BE0-4922-87CA-AE1C0D61A4D8Q35294152-070E4457-4FEA-4C94-9481-1CBF6EE4944DQ35644350-B409FD54-0323-44E6-B172-34A5CC40DDCFQ35664859-0F11C5BB-0239-4254-AD98-4EB0722688EEQ35718765-73DB5084-638F-4B1F-8229-BAC8088187FCQ35744255-EF73D2DA-D023-4703-9F83-627658B48A5DQ35791530-2881E8C1-338D-4FCB-8DA2-D9ED7922E18BQ35832954-FD2497B0-35CE-417D-9161-A770EEDF8F9AQ35836745-96C0F23A-6AD8-4156-8754-D96B37B19647Q35865537-A420E2A3-F433-420E-917E-AF6E07F03A61Q36023613-71315194-EE47-4C79-944F-82A9D6B5D8B2
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Multidrug resistance transporters and modulation.
@ast
Multidrug resistance transporters and modulation.
@en
Multidrug resistance transporters and modulation.
@nl
type
label
Multidrug resistance transporters and modulation.
@ast
Multidrug resistance transporters and modulation.
@en
Multidrug resistance transporters and modulation.
@nl
prefLabel
Multidrug resistance transporters and modulation.
@ast
Multidrug resistance transporters and modulation.
@en
Multidrug resistance transporters and modulation.
@nl
P2093
P1476
Multidrug resistance transporters and modulation.
@en
P2093
P304
P356
10.1097/00001622-200009000-00011
P577
2000-09-01T00:00:00Z